The Alzheimer’s Research UK Conference has an exciting line up of speakers covering a wide range of topics.

Tuesday 23 March – Morning
9:30 – 10:00 Welcomes
   
10:00 – 11:00 Process of drug discovery and design - basic to translational research
  Dr Mike O'Neill (Abbvie): Disease Modifying Drug Discovery Approaches for Alzheimer’s Disease
  Dr Diego Gomez-Nicola (The Oxford Drug Discovery Institute): Steps for de-risking drug discovery projects
  Dr John Davis (University of Southampton): Understanding and targeting neuroinflammation in Alzheimer's disease
  Dr Emily Baker (Cardiff University): To what extent can microglia, synapse and lipid genes be used to inform drug discovery
   
11:00 – 11:15 Break
   
11:15 – 11:45 Prizes
  David Hague Young Investigator of the Year award
  Jean Corsan Prize Winner
   
11:45 – 12:30 Posters and networking
Wednesday 24 March – Morning
9:30 – 10:15 Novel therapies and clinical implications
  Dr Francesco Antonio Aprile (Imperial College London): Antibody discovery for neurodegeneration
  Prof Anne Rosser (Cardiff University): Novel therapies for Huntington's Disease: how did we get here and what is the way ahead?
  Dr Lucy Beishon (University of Leicester): The Effects of Brain Training on Brain Blood Flow: Results from the Cognition and Flow Study (CoGFlowS)
   
10:15 – 10:30 Break
   
10:30 – 11:15 Panel discussion –  clinical trials
  Dr Ben Underwood (University of Cambridge)
  Dr Vanessa Raymont (University of Oxford)
  More speakers will be announced soon.
   
11:15 – 11:30 Break
   
11:30 – 13:00 Early detection of neurodegenerative diseases
  Zoe Kourtzi (intro)
  Dennis Chan
  Chris Hinds
  Zuzana Walker
  Prof Richard Everson
   
13:00 – 13:30 Lunch
   
13:30 – 14:15 Posters and networking
Thursday 25 March – Afternoon
12:30 – 13:30 Viral infection and dementia
Prof Clayton A Wiley (University of Pittsburgh): Viral infection and dementia: A brief synthesis
Associate Prof Colm Cunningham (Trinity College Dublin): Systemic anti-viral responses drive brain interferon and neuroinflammatory activation and can drive progression of neurodegenerative disease
Dr Dervis Salih (University College London): An expression quantitative trait locus associated with oligoadenylate synthetase 1, OAS1, in myeloid cells increases the risk of Alzheimer’s disease and severe Covid-19 outcomes
13:30 – 13:45 Break
13:45 – 14:45 Biomarkers
Prof Nick Fox (University College London): Imaging and biomarkers – from diagnosis to trials – changing roles and recent results
Prof Henrik Zetterberg (University of Gothenburg/University College London): Fluid biomarkers for neurodegenerative dementias - from CSF to blood
Dr Maria Paraskevaidi (University of Central Lancashire): The use of spectroscopic techniques for the non-invasive diagnosis of Alzheimer’s disease
14:45 – 15:30 Posters and networking
Friday 26 March – Afternoon
12:30 – 13:30 Other dementia/tauopathies
Javier Alegre (Imperial College London)
Dr Pete Nelson (University of Kentucky): Pathologic and clinical variability in LATE: focus on quadruple-misfolded proteinopathy
Prof Selina Wray (University College London)
Dr Rachel Waller (The University of Sheffield): What happens to cells of the brain in people who develop dementia after stroke?
13:30 – 13:45 Break
13:45 – 14:45 Neurosensory aspect of Dementia
Dr Maya Koronyo-Hamaoui (Cedars-Sinai Medical Center): Retinal vasculopathy in Alzheimer’s disease: predicting disease status
Prof Jason Warren (University College London): Hearing and Alzheimer’s disease: from ears to brain
Prof Paul Morgan (Cardiff University): Complement as a driver of inflammation in Alzheimer's disease
Miss Karina Vitanova (University College London): Alterations in synaptic transmission at plaque-associated axons in APP knock-in models of Alzheimer's Disease
14:45 – 14:55 Prize presentation
  Laura Pulford Prize
The Iceland Foods Charitable Foundation Communications Prize
The Sir Malcolm Walker Award and The Lady Walker Award